Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04532411
What this trial is testing

COVID-19 Testing Sample Acquisition Throughput and Efficiency

Who this might be right for
SARS-CoV InfectionRespiratory Viral InfectionPersonal Protective Equipment+1 more
Massachusetts General Hospital 28,948
Testing effectiveness (Phase 2)Ended earlyNCT04668209
What this trial is testing

Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus
University of Arizona 31
Testing effectiveness (Phase 2)Ended earlyNCT04335552
What this trial is testing

Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2
Duke University 11
Large-scale testing (Phase 3)UnknownNCT04920838
What this trial is testing

Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

Who this might be right for
Covid19Covid19 Drug TreatmentSevere Acute Respiratory Syndrome Coronavirus 2+1 more
ANRS, Emerging Infectious Diseases 600
Testing effectiveness (Phase 2)Study completedNCT04354870
What this trial is testing

COVID-19 PrEP HCW HCQ Study

Who this might be right for
COVID-19
NYU Langone Health 130
Not applicableUnknownNCT06452069
What this trial is testing

Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients

Who this might be right for
COVID-19 Respiratory InfectionCOVID-19
Biodex S.A 280
Very early researchUnknownNCT04560231
What this trial is testing

Remdesivir in COVID-19 Lahore General Hospital

Who this might be right for
SARS-CoV Infection
Lahore General Hospital 30
Not applicableUnknownNCT04635592
What this trial is testing

Serological Diagnostics of COVID-19 in Health Care Workers

Who this might be right for
SARS-CoV Infection
University Medical Centre Ljubljana 300
Testing effectiveness (Phase 2)UnknownNCT04414098
What this trial is testing

Ruxolitinib in the Treatment of Covid-19

Who this might be right for
COVID-19
Marcelo Iastrebner 100
Not applicableActive Not RecruitingNCT04987528
What this trial is testing

Pulmonary Fibrosis During Severe COVID-19 Pneumonia

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Acute Respiratory Distress SyndromePulmonary Fibrosis
Hôpital Européen Marseille 200
Not applicableUnknownNCT05077163
What this trial is testing

Patients With Acute Renal Failure During Severe COVID-19

Who this might be right for
Renal Failure Chronic
University Hospital, Strasbourg, France 40
Testing effectiveness (Phase 2)Study completedNCT04453384
What this trial is testing

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

Who this might be right for
SARS Virus
Nantes University Hospital 416
Large-scale testing (Phase 3)Ended earlyNCT04860258
What this trial is testing

COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities

Who this might be right for
CoronavirusCovid19SARS-CoV-2+1 more
CureVac 129
Not applicableStudy completedNCT04480580
What this trial is testing

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

Who this might be right for
Covid19SurgerySARS (Severe Acute Respiratory Syndrome)
University of Cagliari 100
Early research (Phase 1)WithdrawnNCT04590274
What this trial is testing

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
International Brain Research Foundation
Not applicableEnded earlyNCT05012280
What this trial is testing

Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID)

Who this might be right for
Covid19Paludism
Institute of Tropical Medicine, Belgium 238
Not applicableStudy completedNCT04933929
What this trial is testing

Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Gérond'if 34
Not applicableUnknownNCT04779021
What this trial is testing

Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department

Who this might be right for
Covid19SARS-CoV Infection
Centre Hospitalier Universitaire de Nice 1,300
Early research (Phase 1)Study completedNCT04766931
What this trial is testing

The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

Who this might be right for
Covid19
Frontier Biotechnologies Inc. 88
Large-scale testing (Phase 3)Ended earlyNCT04642638
What this trial is testing

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVID-19 Disease
Inovio Pharmaceuticals 1,307
Next Page